Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

Area of Science:

• Neurology
• Health Economics
• Healthcare Management

Background:

• Multiple sclerosis (MS) is a chronic, autoimmune central nervous system disease impacting nearly 1 million Americans.
• MS significantly diminishes quality of life and incurs high lifetime care costs, exceeding $4 million per patient.
• Effective and cost-efficient management of MS presents substantial challenges for healthcare stakeholders.

Purpose of the Study:

• To identify and review the key challenges in the cost-effective management of patients with multiple sclerosis.
• To propose a strategic roadmap for healthcare stakeholders to overcome these management challenges.

Main Methods:

• Literature review and synthesis of existing data on MS management.
• Analysis of factors impacting cost-effectiveness, including diagnostic processes and treatment pathways.
• Identification of barriers to optimal patient care and provider coordination.

Main Results:

• Key challenges include limited between-visit clinical data, variability in MRI expertise and standards, misaligned financial incentives, and complex treatment selection.
• Poor patient adherence, inter-provider communication gaps, and lack of objective disease progression measures further complicate management.
• The current coding and reimbursement structure, including limited CPT codes for brain MRI, poses a significant barrier.

Conclusions:

• A holistic, collaborative approach involving insurers, neurologists, researchers, and patient groups is essential for improving MS care.
• Recommendations include standardizing MRI protocols, enhancing specialist access, aligning financial incentives, and streamlining prior authorization for disease-modifying therapies (DMTs).
• Implementing technological solutions for data collection and care coordination, alongside developing better disease activity measurement tools, is critical for advancing patient outcomes.